Key result
Genetic polymorphisms in APOE, GRIN2A, CACNA1E, and SLC17A7 are potential biomarkers of concussion incidence and recovery rate that may improve management and return-to-play decisions.
Why the study?
Does genetic profiling help predict concussion incidence and recovery in athletes?
Does genetic profiling help predict concussion incidence and recovery in athletes?
Answers are grounded in this paper and cite their sources.
Genetic profiling of athletes may offer potential biomarkers for predicting concussion susceptibility and recovery, aiding in individualized management.
Concussion is a traumatic transient disturbance of the brain. In sport, the initial time and severity of concussion is known giving an opportunity for subsequent analysis. Variability in susceptibility and recovery between individual athletes depends, among other parameters, on genetic factors. The genes-encoding polypeptides that determine incidence, severity and prognosis for concussion are the primary candidates for genetic analysis. Genetic polymorphisms in the genes contributing to plasticity and repair (APOE), synaptic connectivity (GRIN2A), calcium influx (CACNA1E), uptake and deposit of glutamate (SLC17A7) are potential biomarkers of concussion incidence and recovery rate. With catalogued genetic variants, prospective genotyping of athletes at the beginning of their career will allow medical professionals to improve concussion management and return-to-play decisions.
No takes yet. Share an insight, caveat, or question.
McDevitt et al. (2017) conducted a review in Sport-related concussions. Genetic polymorphisms (APOE, GRIN2A, CACNA1E, SLC17A7) was evaluated on Concussion incidence and recovery rate. Genetic polymorphisms in APOE, GRIN2A, CACNA1E, and SLC17A7 are potential biomarkers of concussion incidence and recovery rate that may improve management and return-to-play decisions.
Synapse has enriched 10 related papers. Consider them for comparative context: